Progress toward development of vaccines against melioidosis: A review
- 31 August 2010
- journal article
- review article
- Published by Elsevier in Clinical Therapeutics
- Vol. 32 (8) , 1437-1445
Abstract
No abstract availableKeywords
This publication has 58 references indexed in Scilit:
- Vaccines: the Fourth CenturyClinical and Vaccine Immunology, 2009
- A Burkholderia pseudomallei protein microarray reveals serodiagnostic and cross-reactive antigensProceedings of the National Academy of Sciences, 2009
- Immunogenic Burkholderia pseudomallei Outer Membrane Proteins as Potential Candidate Vaccine TargetsPLOS ONE, 2009
- Phenotypic and Functional Characterization of Human Memory T Cell Responses to Burkholderia pseudomalleiPLOS Neglected Tropical Diseases, 2009
- The global distribution of Burkholderia pseudomallei and melioidosis: an updateTransactions of the Royal Society of Tropical Medicine and Hygiene, 2008
- Identification of a LolC Homologue inBurkholderia pseudomallei, a Novel Protective Antigen for MelioidosisInfection and Immunity, 2007
- Development of Signature-Tagged Mutagenesis in Burkholderia pseudomallei To Identify Genes Important in Survival and PathogenesisInfection and Immunity, 2007
- Global Map of Growth-Regulated Gene Expression in Burkholderia pseudomallei , the Causative Agent of MelioidosisJournal of Bacteriology, 2006
- Melioidosis: Epidemiology, Pathophysiology, and ManagementClinical Microbiology Reviews, 2005
- Cytokine Gene Expression in Innately Susceptible BALB/c Mice and Relatively Resistant C57BL/6 Mice during Infection with VirulentBurkholderia pseudomalleiInfection and Immunity, 2000